Early Breast Cancer Patients over 65 Years of Age Prefer Intraoperative Radiation Despite No Survival Benefit

2020 ◽  
Vol 231 (4) ◽  
pp. e83
Author(s):  
Annie Tang ◽  
Caitlin M. Cohan ◽  
Genna Beattie ◽  
Elizabeth L. Cureton ◽  
Jason F. Kelly ◽  
...  
2012 ◽  
Vol 48 ◽  
pp. S101 ◽  
Author(s):  
D. Fontein ◽  
D. Houtsma ◽  
E.T.M. Hille ◽  
W.M. Meershoek-Klein Kranenbarg ◽  
H. Putter ◽  
...  

2020 ◽  
Vol 62 (1) ◽  
pp. 110-118
Author(s):  
Isabel Linares-Galiana ◽  
Miguel Angel Berenguer-Frances ◽  
Rut Cañas-Cortés ◽  
Monica Pujol-Canadell ◽  
Silvia Comas-Antón ◽  
...  

Abstract A detailed understanding of the interactions and the best dose-fractionation scheme of radiation to maximize antitumor immunity have not been fully established. In this study, the effect on the host immune system of a single dose of 20 Gy through intraoperative radiation therapy (IORT) on the surgical bed in low-risk breast cancer patients undergoing conserving breast cancer has been assessed. Peripheral blood samples from 13 patients were collected preoperatively and at 48 h and 3 and 10 weeks after the administration of radiation. We performed a flow cytometry analysis for lymphocyte subpopulations, natural killer cells (NK), regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSCs). We observed that the subpopulation of NK CD56+high CD16+ increased significantly at 3 weeks after IORT (0.30–0.42%, P < 0.001), while no changes were found in immunosuppressive profile, CD4+CD25+Foxp3+Helios+ Treg cells, granulocytic MDSCs (G-MDSCs) and monocytic MDSCs (Mo-MDSCs). A single dose of IORT may be an effective approach to improve antitumor immunity based on the increase in NK cells and the non-stimulation of immunosuppressive cells involved in immune escape. These findings support future combinations of IORT with immunotherapy, if they are confirmed in a large cohort of breast cancer patients.


Sign in / Sign up

Export Citation Format

Share Document